BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17908556)

  • 1. Foxa2 controls vesicle docking and insulin secretion in mature Beta cells.
    Gao N; White P; Doliba N; Golson ML; Matschinsky FM; Kaestner KH
    Cell Metab; 2007 Oct; 6(4):267-79. PubMed ID: 17908556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas Causes Hyperinsulinemic Hypoglycemia.
    Wu Z; Fei A; Liu Y; Pan S
    Am J Ther; 2016; 23(6):e1442-e1448. PubMed ID: 26882312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.
    Gao N; Le Lay J; Qin W; Doliba N; Schug J; Fox AJ; Smirnova O; Matschinsky FM; Kaestner KH
    Mol Endocrinol; 2010 Aug; 24(8):1594-604. PubMed ID: 20534694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.
    Sund NJ; Vatamaniuk MZ; Casey M; Ang SL; Magnuson MA; Stoffers DA; Matschinsky FM; Kaestner KH
    Genes Dev; 2001 Jul; 15(13):1706-15. PubMed ID: 11445544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines.
    Baroukh N; Ravier MA; Loder MK; Hill EV; Bounacer A; Scharfmann R; Rutter GA; Van Obberghen E
    J Biol Chem; 2007 Jul; 282(27):19575-88. PubMed ID: 17462994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxa2 regulates multiple pathways of insulin secretion.
    Lantz KA; Vatamaniuk MZ; Brestelli JE; Friedman JR; Matschinsky FM; Kaestner KH
    J Clin Invest; 2004 Aug; 114(4):512-20. PubMed ID: 15314688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas Causes Hyperinsulinemic Hypoglycemia: RETRACTED.
    Wu Z; Fei A; Liu Y; Pan S
    Am J Ther; 2017; 24(2):e1442-e1448. PubMed ID: 28288081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-stimulated signaling pathways in biphasic insulin secretion.
    Straub SG; Sharp GW
    Diabetes Metab Res Rev; 2002; 18(6):451-63. PubMed ID: 12469359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells.
    Bastidas-Ponce A; Roscioni SS; Burtscher I; Bader E; Sterr M; Bakhti M; Lickert H
    Mol Metab; 2017 Jun; 6(6):524-534. PubMed ID: 28580283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+-secretion coupling is impaired in diabetic Goto Kakizaki rats.
    Rose T; Efendic S; Rupnik M
    J Gen Physiol; 2007 Jun; 129(6):493-508. PubMed ID: 17535961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β-cell function.
    Jia S; Ivanov A; Blasevic D; Müller T; Purfürst B; Sun W; Chen W; Poy MN; Rajewsky N; Birchmeier C
    EMBO J; 2015 May; 34(10):1417-33. PubMed ID: 25828096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurexin-1α contributes to insulin-containing secretory granule docking.
    Mosedale M; Egodage S; Calma RC; Chi NW; Chessler SD
    J Biol Chem; 2012 Feb; 287(9):6350-61. PubMed ID: 22235116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin deficiency causes insulin secretion failure and hyperglycemia.
    Fan F; Wu Y; Hara M; Rizk A; Ji C; Nerad D; Tamarina N; Lou X
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34362840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9
    Alhaidan Y; Christesen HT; Lundberg E; Balwi MAA; Brusgaard K
    Front Endocrinol (Lausanne); 2021; 12():657873. PubMed ID: 34177802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural morphometric analysis of insulin secretory granules in human type 2 diabetes.
    Masini M; Marselli L; Bugliani M; Martino L; Masiello P; Marchetti P; De Tata V
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S247-52. PubMed ID: 23184237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntaxin-4 mediates exocytosis of pre-docked and newcomer insulin granules underlying biphasic glucose-stimulated insulin secretion in human pancreatic beta cells.
    Xie L; Zhu D; Dolai S; Liang T; Qin T; Kang Y; Xie H; Huang YC; Gaisano HY
    Diabetologia; 2015 Jun; 58(6):1250-9. PubMed ID: 25762204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium signaling and secretory granule pool dynamics underlie biphasic insulin secretion and its amplification by glucose: experiments and modeling.
    Pedersen MG; Tagliavini A; Henquin JC
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E475-E486. PubMed ID: 30620637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of Rab27a-dependent actions on vesicle docking and priming in pancreatic beta-cells.
    Merrins MJ; Stuenkel EL
    J Physiol; 2008 Nov; 586(22):5367-81. PubMed ID: 18801842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIDT2 is involved in the NAADP-mediated release of calcium from insulin secretory granules.
    Chang G; Yang R; Cao Y; Nie A; Gu X; Zhang H
    J Mol Endocrinol; 2016 Apr; 56(3):249-59. PubMed ID: 26744456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synapsins I and II are not required for insulin secretion from mouse pancreatic β-cells.
    Wendt A; Speidel D; Danielsson A; Esguerra JL; Bogen IL; Walaas SI; Salehi A; Eliasson L
    Endocrinology; 2012 May; 153(5):2112-9. PubMed ID: 22334712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.